United States Pharmaceuticals

PetIQ Inc (PETQ)

Track

Ticker: PETQ Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PetIQ Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 12 Jun 2024
Value US$4,616,355.46 | Price 180.74 | Shares 67,668 (+27.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-12 S Sale
1.2
Huff Scott
Non-Executive Director
67,668 +27.7%
180.74
US$4,616,355 		67,668 +27.7% 180.74 US$4,616,355
2022-09-07 2022-09-07 B Purchase
3.2
Herrman Robert Michael

GENERAL COUNSEL AND SECRETARY

Officer
91,469 -23.8%
440.89
US$2,593,061 		91,469 -23.8% 440.89 US$2,593,061
2022-09-07 2022-09-06 B Purchase
3.8
Smith Michael A

PRESIDENT

Officer
89,372 +24.8%
154.31
US$301,744 		89,372 +24.8% 154.31 US$301,744
2022-06-22 2022-06-14 B Purchase
1.4
Hall Allan
Non-Executive Director
600 +inf%
15.08
US$9,048 		600 +inf% 15.08 US$9,048
2022-05-24 2022-05-24 B Purchase
3.2
Glasman Zvi

CHIEF FINANCIAL OFFICER

Officer
1,600 +inf%
13.66
US$21,856 		1,600 +inf% 13.66 US$21,856
2022-05-24 2022-05-24 B Purchase
3.2
Glasman Zvi

CHIEF FINANCIAL OFFICER

Officer
5,800 +145.0%
13.73
US$79,634 		5,800 +145.0% 13.73 US$79,634
2022-05-23 2022-05-23 B Purchase
3.8
Smith Michael A

EVP - PRODUCTS

Officer
3,600 +16.4%
14.06
US$50,616 		3,600 +16.4% 14.06 US$50,616
2022-05-23 2022-05-20 B Purchase
3.8
Smith Michael A

EVP - PRODUCTS

Officer
1,400 +6.8%
14.06
US$19,684 		1,400 +6.8% 14.06 US$19,684
2021-12-17 2021-12-17 B Purchase
2.6
SHOLTIS SUSAN

President

Officer
4,750 +110.5%
20.85
US$99,038 		4,750 +110.5% 20.85 US$99,038
2021-12-16 2021-12-14 B Purchase
3.8
Smith Michael A

EVP - Products

Officer
10,000 +250.0%
21.40
US$214,000 		10,000 +250.0% 21.40 US$214,000
2021-12-16 2021-12-14 B Purchase
3.2
Herrman Robert Michael

General Counsel and Secretary

Officer
2,333 +85.5%
21.51
US$50,183 		2,333 +85.5% 21.51 US$50,183
2021-12-02 2021-12-01 B Purchase
3.6
Christensen McCord

Chief Executive Officer

Executive Director
50,000 +712.8%
20.09
US$1,004,500 		50,000 +712.8% 20.09 US$1,004,500
2021-11-15 2021-11-11 B Purchase
3.8
Smith Michael A

EVP - Products

Officer
4,000 +inf%
22.62
US$90,480 		4,000 +inf% 22.62 US$90,480
2021-06-21 2021-06-21 PlS Planned sale
Newland John

Chief Financial Officer

Officer
4,500 -6.6%
40.00
US$180,000 		4,500 -6.6% 40.00 US$180,000
2021-06-14 2021-06-11 S Sale
3.8
Smith Michael A

EVP - Products

Officer
13,470 -100.0%
39.53
US$532,469 		13,470 -100.0% 39.53 US$532,469
2021-06-14 2021-06-10 S Sale
3.8
Smith Michael A

EVP - Products

Officer
2,664 -100.0%
39.80
US$106,027 		2,664 -100.0% 39.80 US$106,027
2021-06-09 2021-06-09 S Sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
5,000 -4.1%
38.72
US$193,600 		5,000 -4.1% 38.72 US$193,600
2021-06-09 2021-06-09 S Sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
5,000 -3.9%
38.70
US$193,500 		5,000 -3.9% 38.70 US$193,500
2021-05-25 2021-05-24 S Sale
2.6
SHOLTIS SUSAN

President

Officer
2,482 -55.3%
41.02
US$101,812 		2,482 -55.3% 41.02 US$101,812
2021-05-24 2021-05-21 PlS Planned sale
Newland John

Chief Financial Officer

Officer
4,500 -6.2%
40.10
US$180,450 		4,500 -6.2% 40.10 US$180,450
2021-05-20 2021-05-19 S Sale
3.8
Smith Michael A

EVP - Products

Officer
16,947 -100.0%
40.11
US$679,744 		16,947 -100.0% 40.11 US$679,744
2021-05-20 2021-05-14 S Sale
3.8
Smith Michael A

EVP - Products

Officer
1,085 -100.0%
40.00
US$43,400 		1,085 -100.0% 40.00 US$43,400
2021-05-18 2021-05-14 S Sale
3.6
Christensen McCord

Chief Executive Officer

Executive Director
111,051 -50.9%
40.00
US$4,442,040 		111,051 -50.9% 40.00 US$4,442,040
2021-05-17 2021-05-13 S Sale
3.6
Christensen McCord

Chief Executive Officer

Executive Director
1,914 -1.8%
40.00
US$76,560 		1,914 -1.8% 40.00 US$76,560
2021-05-12 2021-05-10 S Sale
3.2
Herrman Robert Michael

General Counsel and Secretary

Officer
3,668 -57.3%
42.25
US$154,973 		3,668 -57.3% 42.25 US$154,973
2021-05-12 2021-05-10 S Sale
3.2
Herrman Robert Michael

General Counsel and Secretary

Officer
15,656 -85.2%
42.25
US$661,466 		15,656 -85.2% 42.25 US$661,466
2021-04-23 2021-04-21 PlS Planned sale
Newland John

Chief Financial Officer

Officer
3,102 -4.1%
41.20
US$127,802 		3,102 -4.1% 41.20 US$127,802
2021-04-23 2021-04-21 PlS Planned sale
Newland John

Chief Financial Officer

Officer
1,398 -1.8%
39.91
US$55,794 		1,398 -1.8% 39.91 US$55,794
2021-03-23 2021-03-22 PlS Planned sale
Newland John

Chief Financial Officer

Officer
4,500 -5.5%
36.00
US$162,000 		4,500 -5.5% 36.00 US$162,000
2021-03-16 2021-03-15 S Sale
3.8
Smith Michael A

EVP - Products

Officer
11,213 -91.2%
37.75
US$423,291 		11,213 -91.2% 37.75 US$423,291
2021-03-16 2021-03-15 S Sale
2.6
SHOLTIS SUSAN

President

Officer
10,748 -70.5%
36.04
US$387,358 		10,748 -70.5% 36.04 US$387,358
2021-03-15 2021-03-15 S Sale
3.2
Herrman Robert Michael

General Counsel and Secretary

Officer
464 -14.5%
36.25
US$16,820 		464 -14.5% 36.25 US$16,820
2021-03-12 2021-03-12 S Sale
0.9
ECP HELIOS PARTNERS IV, L.P.
Large shareholder
1,500,000 -43.2%
35.19
US$52,785,000 		1,500,000 -43.2% 35.19 US$52,785,000
2021-03-12 2021-03-12 S Sale
2.3
FIRST MARK L

Non-Employee Director

Non-Executive Director
1,500,000 -43.2%
35.19
US$52,785,000 		1,500,000 -43.2% 35.19 US$52,785,000
2021-03-15 2021-03-11 S Sale
3.2
Herrman Robert Michael

General Counsel and Secretary

Officer
15,655 -91.4%
36.25
US$567,498 		15,655 -91.4% 36.25 US$567,498
2021-03-10 2021-03-09 S Sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
19,269 -13.1%
34.91
US$672,681 		19,269 -13.1% 34.91 US$672,681
2021-03-10 2021-03-08 S Sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
5,000 -3.3%
34.25
US$171,250 		5,000 -3.3% 34.25 US$171,250
2021-03-08 2021-03-05 S Sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
10,000 -6.2%
32.88
US$328,800 		10,000 -6.2% 32.88 US$328,800
2021-03-03 2021-03-01 PlS Planned sale
2.2
Kennedy Ronald

Non-Employee Director

Non-Executive Director
19,269 -10.6%
36.01
US$693,877 		19,269 -10.6% 36.01 US$693,877
2021-03-01 2021-02-25 PlS Planned sale
Newland John

Chief Financial Officer

Officer
4,500 -5.5%
36.00
US$162,000 		4,500 -5.5% 36.00 US$162,000
2021-01-25 2021-01-21 PlS Planned sale
Newland John

Chief Financial Officer

Officer
9,000 -10.4%
36.00
US$324,000 		9,000 -10.4% 36.00 US$324,000
2020-12-30 2020-12-28 PlS Planned sale
Newland John

Chief Financial Officer

Officer
9,000 -9.4%
36.00
US$324,000 		9,000 -9.4% 36.00 US$324,000
2020-08-24 2020-08-20 S Sale
3.8
Smith Michael A

EVP - Products

Officer
2,664 -100.0%
31.50
US$83,916 		2,664 -100.0% 31.50 US$83,916
2020-06-18 2020-06-18 PlS Planned sale
Santana Will
Non-Executive Director
3,333 -11.8%
32.55
US$108,489 		3,333 -11.8% 32.55 US$108,489
2020-06-18 2020-06-17 PlS Planned sale
Santana Will
Non-Executive Director
400 -1.4%
31.97
US$12,788 		400 -1.4% 31.97 US$12,788
2020-06-18 2020-06-17 PlS Planned sale
Santana Will
Non-Executive Director
3,116 -9.8%
32.74
US$102,018 		3,116 -9.8% 32.74 US$102,018
2020-06-18 2020-06-16 PlS Planned sale
Santana Will
Non-Executive Director
13,895 -30.4%
31.21
US$433,663 		13,895 -30.4% 31.21 US$433,663
2020-06-18 2020-06-16 PlS Planned sale
Santana Will
Non-Executive Director
3,605 -7.3%
32.28
US$116,369 		3,605 -7.3% 32.28 US$116,369
2020-06-05 2020-06-05 PlS Planned sale
Santana Will
Non-Executive Director
5,539 -10.1%
30.45
US$168,663 		5,539 -10.1% 30.45 US$168,663
2020-06-05 2020-06-05 PlS Planned sale
Santana Will
Non-Executive Director
11,961 -17.9%
31.00
US$370,791 		11,961 -17.9% 31.00 US$370,791
2020-06-05 2020-06-04 PlS Planned sale
Santana Will
Non-Executive Director
17,500 -20.8%
30.20
US$528,500 		17,500 -20.8% 30.20 US$528,500
2020-06-05 2020-06-03 PlS Planned sale
Santana Will
Non-Executive Director
4,045 -4.6%
30.07
US$121,633 		4,045 -4.6% 30.07 US$121,633
2020-06-05 2020-06-03 PlS Planned sale
Santana Will
Non-Executive Director
13,273 -13.1%
30.45
US$404,163 		13,273 -13.1% 30.45 US$404,163
2020-03-16 2020-03-13 B Purchase
3.2
Herrman Robert Michael

General Counsel
1,004 +216.4%
19.85
US$19,929 		1,004 +216.4% 19.85 US$19,929
2020-03-10 2020-03-04 PlS Planned sale
Santana Will

Executive Vice President
3,434 -3.3%
30.22
US$103,775 		3,434 -3.3% 30.22 US$103,775
2020-02-25 2020-02-21 PlS Planned sale
Santana Will

Executive Vice President
1,300 -3.4%
31.00
US$40,300 		1,300 -3.4% 31.00 US$40,300
2020-02-25 2020-02-21 PlS Planned sale
Santana Will

Executive Vice President
2,333 -5.7%
36.74
US$85,714 		2,333 -5.7% 36.74 US$85,714
2020-02-20 2020-02-20 PlS Planned sale
Santana Will

Executive Vice President
3,823 -8.6%
34.17
US$130,632 		3,823 -8.6% 34.17 US$130,632
2020-02-20 2020-02-20 PlS Planned sale
Santana Will

Executive Vice President
4,344 -8.9%
34.58
US$150,216 		4,344 -8.9% 34.58 US$150,216
2020-02-20 2020-02-19 PlS Planned sale
Santana Will

Executive Vice President
7,666 -13.6%
34.03
US$260,874 		7,666 -13.6% 34.03 US$260,874
2020-02-20 2020-02-19 PlS Planned sale
Santana Will

Executive Vice President
9,834 -14.8%
34.71
US$341,338 		9,834 -14.8% 34.71 US$341,338
2020-02-05 2020-02-05 PlS Planned sale
Santana Will

Executive Vice President
17,500 -20.9%
31.00
US$542,500 		17,500 -20.9% 31.00 US$542,500
2020-02-05 2020-02-04 PlS Planned sale
Santana Will

Executive Vice President
4,300 -4.9%
30.72
US$132,096 		4,300 -4.9% 30.72 US$132,096
2020-02-05 2020-02-04 PlS Planned sale
Santana Will

Executive Vice President
13,200 -13.0%
31.02
US$409,464 		13,200 -13.0% 31.02 US$409,464
2020-02-05 2020-02-03 PlS Planned sale
Santana Will

Executive Vice President
3,600 -3.4%
30.04
US$108,144 		3,600 -3.4% 30.04 US$108,144
2020-01-27 2020-01-24 PlS Planned sale
Santana Will

Executive Vice President
17,500 -25.0%
30.61
US$535,675 		17,500 -25.0% 30.61 US$535,675
2020-01-24 2020-01-23 PlS Planned sale
Santana Will

Executive Vice President
17,500 -20.0%
30.39
US$531,825 		17,500 -20.0% 30.39 US$531,825
2020-01-24 2020-01-22 PlS Planned sale
Santana Will

Executive Vice President
17,500 -16.7%
30.22
US$528,850 		17,500 -16.7% 30.22 US$528,850
2019-11-13 2019-11-12 B Purchase Newland John

Chief Financial Officer
44,000 +inf%
22.28
US$980,148 		44,000 +inf% 22.28 US$980,148
2019-08-22 2019-08-22 PlS Planned sale Santana Will

Executive Vice President
3,333 -14.3%
31.84
US$106,123 		3,333 -14.3% 31.84 US$106,123
2019-08-22 2019-08-21 PlS Planned sale Santana Will

Executive Vice President
2,483 -9.6%
31.99
US$79,431 		2,483 -9.6% 31.99 US$79,431
2019-08-22 2019-08-21 PlS Planned sale Santana Will

Executive Vice President
850 -3.2%
32.76
US$27,846 		850 -3.2% 32.76 US$27,846
2019-08-22 2019-08-20 PlS Planned sale Santana Will

Executive Vice President
3,334 -11.1%
32.98
US$109,955 		3,334 -11.1% 32.98 US$109,955
2019-08-07 2019-08-07 PlS Planned sale Santana Will

Executive Vice President
1,817 -5.7%
31.40
US$57,054 		1,817 -5.7% 31.40 US$57,054
2019-08-07 2019-08-07 PlS Planned sale Santana Will

Executive Vice President
1,516 -4.5%
32.22
US$48,846 		1,516 -4.5% 32.22 US$48,846
Explore more

More insider trading research around PetIQ Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America